Exposure–response analysis of alectinib in crizotinib-resistant ALK-positive non-small cell lung cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0843
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Exposure–response analysis of alectinib in crizotinib-resistant ALK-positive non-small cell lung cancer ; volume:82 ; number:1 ; day:10 ; month:5 ; year:2018 ; pages:129-138 ; date:7.2018
Cancer chemotherapy and pharmacology ; 82, Heft 1 (10.5.2018), 129-138, 7.2018
- Creator
-
Morcos, Peter N.
- Contributor
-
Nueesch, Eveline
Jaminion, Felix
Guerini, Elena
Hsu, Joy C.
Bordogna, Walter
Balas, Bogdana
Mercier, Francois
SpringerLink (Online service)
- DOI
-
10.1007/s00280-018-3597-5
- URN
-
urn:nbn:de:101:1-2018083022550866448143
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Morcos, Peter N.
- Nueesch, Eveline
- Jaminion, Felix
- Guerini, Elena
- Hsu, Joy C.
- Bordogna, Walter
- Balas, Bogdana
- Mercier, Francois
- SpringerLink (Online service)
Other Objects (12)
ALK Inhibitors in Nonsmall Cell Lung Cancer
Gingival Metastasis of ALK Rearranged Non-Small Cell Lung Cancer
Comparing Genomic Profiles of ALK Fusion-Positive and ALK Fusion-Negative Nonsmall Cell Lung Cancer Patients
Second- and third-generation ALK inhibitors for non-small cell lung cancer
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients
Vulnerability of drug‐resistant EML4‐ALK rearranged lung cancer to transcriptional inhibition
Retrospective Observational Study of ALK-Inhibitor Therapy Sequencing and Outcomes in Patients with ALK-Positive Non-small Cell Lung Cancer
The combined effect of ALK inhibitors and radiotherapy in non-small cell lung cancer
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
Personalized medicine: paradigm shift in ALK positive non-small cell lung cancer: a case report
Cell of origin and fusion variants of Eml4-Alk in non-small cell lung cancer
Primary Resistance to ALK Inhibitors in a Patient with Nonsmall Cell Lung Cancer with ALK Rearrangement: A Case Report with Review of Literature
ALK Inhibitors in Nonsmall Cell Lung Cancer
Gingival Metastasis of ALK Rearranged Non-Small Cell Lung Cancer
Comparing Genomic Profiles of ALK Fusion-Positive and ALK Fusion-Negative Nonsmall Cell Lung Cancer Patients
Second- and third-generation ALK inhibitors for non-small cell lung cancer
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients
Vulnerability of drug‐resistant EML4‐ALK rearranged lung cancer to transcriptional inhibition
Retrospective Observational Study of ALK-Inhibitor Therapy Sequencing and Outcomes in Patients with ALK-Positive Non-small Cell Lung Cancer
The combined effect of ALK inhibitors and radiotherapy in non-small cell lung cancer
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
Personalized medicine: paradigm shift in ALK positive non-small cell lung cancer: a case report
Cell of origin and fusion variants of Eml4-Alk in non-small cell lung cancer
Primary Resistance to ALK Inhibitors in a Patient with Nonsmall Cell Lung Cancer with ALK Rearrangement: A Case Report with Review of Literature
ALK Inhibitors in Nonsmall Cell Lung Cancer
Gingival Metastasis of ALK Rearranged Non-Small Cell Lung Cancer
Comparing Genomic Profiles of ALK Fusion-Positive and ALK Fusion-Negative Nonsmall Cell Lung Cancer Patients
Second- and third-generation ALK inhibitors for non-small cell lung cancer
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients
Vulnerability of drug‐resistant EML4‐ALK rearranged lung cancer to transcriptional inhibition
Retrospective Observational Study of ALK-Inhibitor Therapy Sequencing and Outcomes in Patients with ALK-Positive Non-small Cell Lung Cancer
The combined effect of ALK inhibitors and radiotherapy in non-small cell lung cancer
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
Personalized medicine: paradigm shift in ALK positive non-small cell lung cancer: a case report
Cell of origin and fusion variants of Eml4-Alk in non-small cell lung cancer